{"name":"Vaderis Therapeutics AG","slug":"vaderis-therapeutics-ag","ticker":"","exchange":"","domain":"vaderis.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.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?oc=5","date":"2025-12-02","type":"pipeline","source":"prnewswire.com","summary":"Vaderis Therapeutics Announces The New England Journal of Medicine Publishes Engasertib Proof-of-Concept and Long-Term Extension Results, Highlighting the Therapy's Potential for Patients with Heredit","headline":"Vaderis Therapeutics Announces The New England Journal of Medicine Publishes Engasertib Proof-of-Concept and Long-Term E","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxQalB0Yk54aGNTaE82Si10TWZ0a0xnRXRBdG9sMUpjdG5JZlJVQXNPQkg3Q3phSVFxWklMc0pUVG5mYjZKbTRldWhPYWNXTmFmMlZ2QTJBUmhqeUFtMmVPOTRPbGZ4YjB1UUZoVmJOSjZCRXZQSjB1T25HMDlVdm5LR3ZsRUlWTVZzX0EyekxvVURaZldjRmZrUXhqcV9vTDluZDVqVEl6SjNkWXFpcEZtS1N1UEZ1cHEwOXlfMDdn?oc=5","date":"2024-08-27","type":"trial","source":"prnewswire.com","summary":"Vaderis Announces Positive Clinical Proof-of-Concept Trial in HHT - prnewswire.com","headline":"Vaderis Announces Positive Clinical Proof-of-Concept Trial in HHT","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMi_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?oc=5","date":"2024-06-26","type":"pipeline","source":"prnewswire.com","summary":"Vascular Malformations Market to Grow Substantially by 2034, Assesses DelveInsight | Key Companies - ARTham Therapeutics, Neurelis, Protara Therapeutics, Recursion, Genentech, Vascular Therapies, Palv","headline":"Vascular Malformations Market to Grow Substantially by 2034, Assesses DelveInsight | Key Companies - ARTham Therapeutics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi-wFBVV95cUxQenFIYlFDWW1ybFdnemc5aGRESWdVanRLMENad0tIcUFSWDlGSkFDWmltamtCTE0zZC1XUmh2eG1pQTMxRUVpQjk5R1FwUDM5RlR0NGJqdDlLN2ZBWW5wNFFyTmotYV9sRmdQR1czZFRtTGcyVEZNZGdROGN1RXNrb3p5RzU4N292cGFHMU1LUXhyV1dUeFFIYlA2dTBQejFqNmozdXJsMmxqSzdQWEEySXAyYV9sN19zdDc4cFdPM2VPUDFxZTBMQXZLcGJaYTRkMWRJYjZZMzVEd0NxUlhIb2RBcUl4SThwZ0MzRGY0TFY2OVYza3E2VHNkdw?oc=5","date":"2022-08-22","type":"trial","source":"prnewswire.com","summary":"Vaderis Therapeutics AG Emerges from Stealth and Announces Initiation of Clinical Proof-of-Concept Trial in HHT - prnewswire.com","headline":"Vaderis Therapeutics AG Emerges from Stealth and Announces Initiation of Clinical Proof-of-Concept Trial in HHT","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMid0FVX3lxTE1xbzRia1gwQmR5TkRSbTdoeldWc1MzSFhEOTlOcGM1Y1lFSW93TklpWXUza0hhb0Itby00TVdpM0lhcE1xVlBkWFFiRjlNR1JIY2pzQUFPQ3NabW5jU24xTjNXVXpFNGZxN2J5MldzWG11S2UxUVpz?oc=5","date":"2022-08-22","type":"trial","source":"labiotech.eu","summary":"Vaderis emerges from stealth to start HTT trial - labiotech.eu","headline":"Vaderis emerges from stealth to start HTT trial","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxPTk9zOHRHOHdRdVdZZmxXYmJpYWpNc0RBRExCX3B6djFOeVRMcDZuTW52UDZoZGQwcTFHR01WaXRWN2lUOGNEV3JvOWNEVXdVbnBIY09SWl9PeDRGOUd4VldhNmNHM1ozcXBJcnQ2b1hFOHJWdHJHelFlU3R6M21EcHBOTDlYdW5IV09ST2J1YmE2RGI5dnRnOVc0YzExR0d6N3IzS2pfZWc?oc=5","date":"2022-08-22","type":"pipeline","source":"BioSpace","summary":"Vaderis Forms to Tackle Vascular Malformations with Novartis Vet at the Helm - BioSpace","headline":"Vaderis Forms to Tackle Vascular Malformations with Novartis Vet at the Helm","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxNVFNiNkpoQ3FPNHp1enZtNUpRSnR2dWl5NmpwcUdpUUFXRlByTkphUlAybG01MmoyTm55UVNuQ0YwYmd4WTU2LTk0Q0laQzBrNElTMEpQcFFZMmJwMUJJakVfY2lyTlVJdTJuVHZzYUFlQVN3VnhLSlEwYUNUQjZJMHJ6VDlraDJOZ3JwMQ?oc=5","date":"2021-05-13","type":"pipeline","source":"Yeshiva University","summary":"Webinar Series on Business and Entrepreneurship in Biotech - Yeshiva University","headline":"Webinar Series on Business and Entrepreneurship in Biotech","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}